SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-014525
Filing Date
2021-08-05
Accepted
2021-08-05 18:01:45
Documents
2
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4061
2 POWER OF ATTORNEY poa.htm EX-24 6472
  Complete submission text file 0001567619-21-014525.txt   11909
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 U.S. 9 SUITE 500 MANALAPAN TOWNSHIP NJ 07726
Business Address
Gesek Andrew (Reporting) CIK: 0001833990 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 211149863